echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Notice on Publicly Soliciting Opinions on the "Technical Guidelines for Clinical Pharmacology Research of Biosimilar Drugs (Draft for Solicitation of Comments)"

    Notice on Publicly Soliciting Opinions on the "Technical Guidelines for Clinical Pharmacology Research of Biosimilar Drugs (Draft for Solicitation of Comments)"

    • Last Update: 2021-08-10
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    In recent years, the research and development and application of biosimilar drugs has increased
    .


    Clinical pharmacology research is an important content in the comparison of biosimilar drugs, and it is very important to support the similarity evaluation of the effectiveness and safety of biosimilar drugs and reference drugs


    We sincerely welcome valuable comments and suggestions from all walks of life on the solicitation draft, and timely feedback to us for follow-up improvement
    .


    The time limit for soliciting opinions is 1 month from the date of publication


    Please send your feedback to the mailbox of the following contact:

    Contact: Wang Yuzhu; Li Jian

    Contact: wangyzh@cde.


    Thank you for your participation and great support


    Drug Evaluation Center of the State Drug Administration

    July 8, 2021

    attachment1 : "Technical Guidelines for Clinical Pharmacology Research of Biosimilar Drugs (Draft for Solicitation of Comments)".
    pdf
    Annex 2: Drafting Instructions for "Technical Guidelines for Clinical Pharmacology Research of Biosimilar Drugs (Draft for Comment)".
    pdf
    Annex 3 : "Technical Guidelines for Clinical Pharmacology Research of Biosimilar Drugs (Draft for Solicitation of Comments)" feedback form.
    docx
    attachment1 : "Technical Guidelines for Clinical Pharmacology Research of Biosimilar Drugs (Draft for Solicitation of Comments)".
    pdf Annex 2: Drafting Instructions for "Technical Guidelines for Clinical Pharmacology Research of Biosimilar Drugs (Draft for Solicitation of Comments)".
    pdf Annex 3: "Technical Guidelines for Clinical Pharmacology Research of Biosimilar Drugs (Draft for Solicitation of Comments)" feedback form.
    docx Annex 1: "Technical Guidelines for Clinical Pharmacology Research of Biosimilar Drugs (Draft for Solicitation of Comments)".
    pdf Annex 1: "Technical Guidelines for Clinical Pharmacology Research of Biosimilar Drugs (Draft for Solicitation of Comments)".
    pdf "Technical Guidelines for Clinical Pharmacology Research of Biosimilar Drugs (Draft for Solicitation of Comments)".
    pdf Annex 2: Drafting Instructions for "Technical Guidelines for Clinical Pharmacology Research of Biosimilar Drugs (Draft for Solicitation of Comments)".
    pdf Annex 2: Drafting Instructions for "Technical Guidelines for Clinical Pharmacology Research of Biosimilar Drugs (Draft for Comment)".
    pdf Drafting Instructions for "Technical Guidelines for Clinical Pharmacology Research of Biosimilar Drugs (Draft for Solicitation of Comments)".
    pdf Annex 3: "Technical Guidelines for Clinical Pharmacology Research of Biosimilar Drugs (Draft for Comment)" feedback form.
    docx Annex 3: "Technical Guidelines for Clinical Pharmacology Research of Biosimilar Drugs (Draft for Solicitation of Comments)" feedback form.
    docx "Technical Guidelines for Clinical Pharmacology Research of Biosimilar Drugs (Draft for Solicitation of Comments)" feedback form.
    docx
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.